Contribution of adenosine A2A receptor agonist and antagonist on ovarian ischemia/reperfusion injury in rats
Turkish Journal of Medical Sciences · 12.02.2026 · 56 (1) · 364-376
DOI: 10.55730/1300-0144.6170 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 12.02.2026. Verfasst von Azad Mammadov und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Pharmacology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkiye. Hauptthemen laut MEDLINE: Reperfusion Injury, Purines, Adenosine A2 Receptor Antagonists, Ovary. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/aim: To determine the effects of an A2A receptor agonist regadenoson, an A2A receptor antagonist istradefylline, and istradefylline nanosuspension on ovarian ischemia/reperfusion (I/R) injury in rats. Materials and methods: A total of 80 female rats were divided into 10 groups: sham, ovarian I/R, blank nanosuspension + ovarian I/R, regadenoson (3 μg/kg) + ovarian I/R, regadenoson (30 μg/kg) + ovarian I/R, istradefylline (0.3 mg/kg) + ovarian I/R, istradefylline (3 mg/kg) + ovarian I/R, istradefylline-loaded nanosuspension (3 mg/kg) + ovarian I/R, istradefylline (3 mg/kg) + regadenoson (30 μg/kg) + ovarian I/R, and istradefylline-loaded nanosuspension (3 mg/kg) + regadenoson (30 μg/kg) + ovarian I/R. ELISA, chemiluminescence, and spectrophotometric analyses were performed on blood and ovarian tissue samples. Histopathological changes were analyzed using hematoxylin and eosin staining, and a scoring system was applied to assess ovarian tissue damage.
Results
Serum malondialdehyde levels were augmented in the I/R and blank nanosuspension + I/R groups. Although tissue superoxide dismutase levels were decreased with I/R, these levels were increased with regadenoson (3 μg/kg), istradefylline (0.3–3 mg/kg), and istradefylline nanosuspension (3 mg/kg). While there was augmentation in the serum and tissue 3-nitrotyrosine levels in the I/R group, a marked decrease was identified with regadenoson (30 μg/kg, p < 0.05). Native thiol levels were decreased in the I/R group, and this decrease was prevented by regadenoson. Serum disulfide levels were increased in the I/R group, and this increase was suppressed by regadenoson.
Conclusion
These data showed that adenosine A2A receptors may contribute to the ovarian I/R injury and regadenoson can produce protective effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Pharmacology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkiye.
- Department of Pharmaceutical Technology, Faculty of Pharmacy, Biruni University, İstanbul, Turkiye.
- Department of Medical Pathology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkiye.
- Department of Physiology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkiye.
ORCID-Profile: Azad Mammadov, Abdullah Tuncay Demiryürek, Ahmet Saracaloğlu, Cahit Demirkiran, İsmail Tuncer Değim, Ömer Eronat, Şeniz Demiryürek
Zitieren
APA
Mammadov, A., Demiryürek, A. T., Saracaloğlu, A., Demirkiran, C., Değim, İ. T., Eronat, Ö., & Demiryürek, Ş. (2026). Contribution of adenosine A2A receptor agonist and antagonist on ovarian ischemia/reperfusion injury in rats. Turkish Journal of Medical Sciences, 56(1), 364-376. https://doi.org/10.55730/1300-0144.6170
Vancouver
Mammadov A, Demiryürek AT, Saracaloğlu A, Demirkiran C, Değim İT, Eronat Ö, et al. Contribution of adenosine A2A receptor agonist and antagonist on ovarian ischemia/reperfusion injury in rats. Turkish Journal of Medical Sciences. 2026;56(1):364-376. doi:10.55730/1300-0144.6170
BibTeX
@article{Mammadov2026,
author = {Mammadov, Azad and Demiryürek, Abdullah Tuncay and Saracaloğlu, Ahmet and Demirkiran, Cahit and Değim, İsmail Tuncer and Eronat, Ömer and Demiryürek, Şeniz},
title = {Contribution of adenosine A2A receptor agonist and antagonist on ovarian ischemia/reperfusion injury in rats},
journal = {Turkish Journal of Medical Sciences},
year = {2026},
volume = {56},
number = {1},
pages = {364--376},
doi = {10.55730/1300-0144.6170}
}
EUVIMED